Aclaris Therapeutics, Inc.

Contributing Author

Recent Articles by Aclaris Therapeutics, Inc.

14 hours	Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis ACRS GlobeNewswire
May-28	Aclaris Therapeutics to Participate in Two June Healthcare Conferences ACRS GlobeNewswire
May-09	Aclaris Therapeutics to Participate in the HC Wainwright "HCW@Home" Series ACRS GlobeNewswire
May-08	Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update ACRS GlobeNewswire